跳至主要内容
临床试验/ISRCTN98817459
ISRCTN98817459已完成不适用

Immunomodulatory effects of a proprietary Arabinogalactan extract: a randomised double-blind placebo controlled parallel group study

onza, Inc (USA)0 个研究点目标入组 50 人开始时间: 2009年8月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Aged 18 to 65 years, either sex
  • 2. Had a Body Mass Index (BMI) greater than 18 kg/m^2 and less than 30 kg/m^2 at screening
  • 3. Agreed to all study visits and visit procedures
  • 4. Agreed to use appropriate forms of birth control if females of child bearing potential
  • 5. Agreed not to initiate/change any exercise or diet programs during the study

排除标准

  • 1. Previously had the pneumococcal vaccine
  • 2. Had allergies to the test product
  • 3. Had any major systemic, inflammatory or chronic disease
  • 4. Had any active infection or infection in the past month requiring antibiotics or anti-viral medication
  • 5. Used immunosuppressive drugs in the prior 5 years
  • 6. Known alcohol or drug abuse
  • 7. Were pregnant or lactating
  • 8. Had any medical condition which in the opinion of the investigator might interfere with the subject's ability in the trial

研究者

发起方
onza, Inc (USA)

相似试验